Bays HE, Dujovne CA. Drug interactions of lipid-altering drugs. Drug
Saf. 1998;19(5):355-371.
Ding RW, Kolbe K, Merz B, de Vries J, Weber E, Benet Z. Pharmacokinetics of
nicotinic acid-salicylic acid interaction. Clin Pharmacol Ther.
1989;46(6):642-647.
Gardner SF, Marx MA, White LM, et al. Combination of low-dose niacin and
pravastatin improves the lipid profile in diabetic patients without compromising
glycemic control. Ann Pharmacother. 1997;31(6):677-682.
Garg A. Lipid-lowering therapy and macrovascular disease in diabetes
mellitus. Diabetes. 1992;41(Suppl 2):111-115.
Gurakar, A, Hoeg, J, Kostner, G, et al. Levels of lipoprotein Lp(a) decline
with neomycin and niacin treatment. Atheroscl. 1985;57:293-301.
Guyton JR, Goldberg AC, Kreisberg RA, et al. Effectiveness of once-nightly
dosing of extended-release niacin alone and in combination for
hypercholsterolemia. Am J Cardiol. 1998;82(6):737-743.
Hill MD, Bilbao JM. Case of the month: February
1999—54 year old man with severe muscle weakness.
Brain Pathol. 1999;9(3):607-608.
Jokubaitis LA. Fluvastatin in combination with other lipid-lowering agents.
Br J Clin Pract. 1996;Suppl. Jan;77A:28-32.
Omray A. Evaluation of pharmacokinetic parameters of tetracylcine
hydrochloride upon oral administration with vitamin C and vitamin B complex.
Hindustan Antibiot Bull. 1981;23(VI):33-37.
Physicians' Desk Reference, PDR. 54th ed. Montvale, NJ: Medical Economics
Company; 2000.
Rockwell KA. Potential interaction between niacin and transdermal nicotine.
Ann Pharmacother. 1993;27(10):1283-1288.
Visalli N, Cavallo MG, Signore A, et al. A multi-centre randomized trial of
two different doses of nicotinamide in patients with recent-onset type 1
diabetes (the IMDIAB VI). Diabetes Metab Res Rev. 1999;15(3):181-185.
Whelan AM, Price SO, Fowler SF, et al. The effect of aspirin on
niacin-induced cutaneous reactions. J Fam Pract. 1992;34(2):165-168.
Yee HS, Fong NT, Atorvastatin in the treatment of primary
hypercholesterolemia and mixed dyslipidemias. Ann Pharmacother. 1998
Oct;32(10):1030-1043.